Companies · Healthtech

Eden Health, Inc.

New York · Healthtech · refined from filed group “Other Technology

Diligence memoA one-page analyst read on Eden Health, Inc. — recommendation, valuation, rhythm, risks.
$73.4M
Total raised · real
3
Rounds
6.2×
Latest step-up
Top 7%
Sector rank · raised
Series C
Latest stage · inferred · Fri Feb 05 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

Eden Health, Inc. looks fair against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the healthtech sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Fair
  • Modeled value is 1.19× the median modeled value of Series C Healthtech companies in 2019–2021 (33 peers) — value vs value, same stage and era.
  • Within the normal band (119% of peer median) for its niche.
Dormant
  • Last raise 5.4 yr ago; this sector typically re-raises about every 14 months.
  • Silent for over 3× the sector's normal cadence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Healthtech

Eden Health, Inc. is one of 2138 Healthtech companies tracked from New York. By capital raised it ranks among the largest (ahead of 94% of sector peers), and among the largest by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
18
Investors (latest)
2021-02-05
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$500M$1.0B$1.5B$2.0BSeed · 2017-11-10 Raised $3.8M (real) Modeled valuation $106M (est)$3.8M$106MSeed2017Series A · 2018-12-14 Raised $9.6M (real) Modeled valuation $217M (est)$9.6M$217MSeries A2018Series C · 2021-02-05 Raised $60M (real) Modeled valuation $1.3B (est)$60M$1.3BSeries C2021+$9.6M+$60MCumulative $73M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Seed$3.8M · 2017
Series A$9.6M · 2018
Series C$60.0M · 2021no Series B on file

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed, Series B — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 60%.

Modeled valuation trajectory
$1.3B
Base estimate est.
$218.1M
Conservative case
$3.2B
Upside case
$400.0M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Ca $40M–$100M round). Valuation is modeled from stage benchmarks scaled by the healthtech sector profile. Directional, not a quoted figure.

Seed · modeled $105.5M · 2017-11-102017Series A · modeled $217.3M · 2018-12-14Series C · modeled $1.3B · 2021-02-052021
Model inputs · modeled:benchmark-stage-stepup-v1
15%
Dilution assumption
Implied ownership sold in the financing.
73%
Survival probability
55% low · 85% high
1.32×/yr
Annual markup
1.51×/yr upside case
5.4 yr
Elapsed time used
5.4 yr actual, capped for stale marks
healthtech
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
19 mo
Avg between rounds
$22.7M/yr
Capital velocity
8.6 yr
On record since
2017
First round
3
Rounds on file
How it compares to the market

Benchmarked against 2138 companies in Healthtech. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 16× above median
This company$73.4M
Sector median$4.5M
Latest round — vs other Series C rounds in sector (real $, this stage) 1.3× above median
This company$60.0M
Sector median$46.5M
Modeled value — vs sector median (estimate, all stages) 38× above median
This company$1.3B
Sector median$33.8M

Raised more than 94% of sector peers (real $). Modeled value above 98% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series C) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #11 of 33.

This companyCohort peer
$1.0B$10.0B$10.0M$100.0M$1.0BCapital raised (log)Virta Health Corp. · Series C Raised $122.0M · modeled $2.4B (est)Fresenius Medical Care Voorhees, LLC · Series C Raised $71.1M · modeled $1.8B (est)Clear Health Pass Holdings LLC · Series C Raised $100.0M · modeled $1.8B (est)Zealth, Inc. · Series C Raised $95.0M · modeled $1.7B (est)Jawbone Health Hub, Inc. · Series C Raised $65.4M · modeled $1.7B (est)Boston Health Economic Holdings, LLC · Series C Raised $63.0M · modeled $1.6B (est)PWN Health Holdings, Inc. · Series C Raised $61.8M · modeled $1.5B (est)Quartet Health, Inc. · Series C Raised $127.0M · modeled $1.4B (est)Workit Health, Inc. · Series C Raised $87.9M · modeled $1.4B (est)Ajax Health II LLC · Series C Raised $51.0M · modeled $1.3B (est)NeuSpera Medical Inc. · Series C Raised $88.6M · modeled $1.3B (est)Eden Health, Inc. (this company) Raised $73.4M · modeled $1.3B (est)Eden Health, Inc.
CompanyStageRaised · realValue · estvs peer med.
Virta Health Corp.Series C$122.0M$2.4B2.19×
Fresenius Medical Care Voorhees, LLCSeries C$71.1M$1.8B1.67×
Clear Health Pass Holdings LLCSeries C$100.0M$1.8B1.67×
Zealth, Inc.Series C$95.0M$1.7B1.55×
Jawbone Health Hub, Inc.Series C$65.4M$1.7B1.54×
Boston Health Economic Holdings, LLCSeries C$63.0M$1.6B1.48×
PWN Health Holdings, Inc.Series C$61.8M$1.5B1.39×
Quartet Health, Inc.Series C$127.0M$1.4B1.29×
Workit Health, Inc.Series C$87.9M$1.4B1.27×
Ajax Health II LLCSeries C$51.0M$1.3B1.20×
Eden Health, Inc. this companySeries C$73.4M$1.3B1.19×
NeuSpera Medical Inc.Series C$88.6M$1.3B1.19×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Seed$3.8M2017-11-10$19.0M$105.5M90%
Series A$9.6M2018-12-14$43.7M$217.3M90%
Series C$60.0M2021-02-05$400.0M$1.3B90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Seed$3.8M2017-11-10
    • First recorded raise — entered as Seed.
    • 35 investors on this round.
  2. Series A$9.6M2018-12-14
    • Raised 13 mo later, in step with the ~14 mo sector norm.
    • Round 2.5× larger than the prior — scaling up.
    • 15 investors on this round.
  3. Series C$60.0M2021-02-05
    • Raised again after 26 mo — slower than the ~14 mo sector norm.
    • Round 6.2× larger than the prior — scaling up.
    • 18 investors on this round.
Intelligence
2022 ~Q3
Modeled next raise · ~19mo cadence
$180.0M
Modeled next size est.range $117.0M$288.0M
6.2×
Last step-up
$22.7M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Benjamin Luke Stein2017-11
Dan Luke Gebremedhin2021-02
Ellie Luke Wheeler2018-12
Jason Luke Lee2021-02
John Luke Stoddard2021-02
Joseph Luke Wiener2018-12
Matthew Johnson McCambridge2017-11
Scott Luke Sansovich Jr.2017-11
Registry & provenance

Eden Health, Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1721728
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Columbia Africa Healthcare, LLCHealthtechSeries C$75.0M$580.2Msame sector · same stage
Fresenius Medical Care Voorhees, LLCHealthtechSeries C$71.1M$1.8Bsame sector · same stage
Stellar Health Group, Inc.HealthtechSeries C$71.1M$1.1Bsame sector · same stage
Form Health, Inc.HealthtechSeries C$76.0M$370.2Msame sector · same stage
Health Intelligence Co LlcHealthtechSeries C$70.6M$1.1Bsame sector · same stage
Brightside Health, Inc.HealthtechSeries C$69.9M$800.8Msame sector · same stage
Employee Health Holdings, LPHealthtechSeries C$78.8M$779.7Msame sector · same stage
Ophelia Health, Inc.HealthtechSeries C$68.4M$859.9Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Eve Health Systems, Inc.HealthtechPre-Seed$2.4M89%
Edenbridge Health, Inc.HealthtechSeed$27.7M89%
Healthe, Inc.HealthtechSeries B$465.2M87%
Healthcare, Inc.HealthtechSeries D+$4.0B87%
Abax Health, Inc.HealthtechSeries A$14.6M87%
Oto Health Inc.HealthtechSeed$36.8M86%
Novo Health Inc.HealthtechSeed$43.5M86%
Juniper Health, Inc.HealthtechSeed$21.3M86%
Frequently asked
How much funding has Eden Health, Inc. raised?
Eden Health, Inc. has raised approximately $73.4M in disclosed capital across 3 recorded financing rounds, aggregated from public filings.
What is Eden Health, Inc.'s estimated valuation?
Provath's modeled valuation for Eden Health, Inc. is approximately $1.3B (modeled range $218.1M–$3.2B). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Eden Health, Inc. at?
Eden Health, Inc.'s latest modeled financing stage is Series C. Its most recent recorded round closed around Fri Feb 05.
What does Eden Health, Inc. do and where is it based?
Eden Health, Inc. operates in the Healthtech sector, based in New York.
Explore related

See where Eden Health, Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Eden Health, Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.